Springer shifts journal Autoimmunity Highlights to open access

While publication model changed, audience and content remain the same

New York, 28 January 2015

Springer has assumed control of the journal Autoimmunity Highlights, which was previously owned by A. Menarini Diagnostics, an Italian company. In doing so Springer has also elected to make the journal an open access (OA) publication, which will allow for its published findings to be immediately available. However, readers should not expect any changes in the high quality of the content.

Autoimmunity Highlights presents material of interest to diverse professionals working on autoimmune diseases, and examines all aspects including diagnosis, treatment and management. The journal offers specific coverage of all autoimmune diseases, including rheumatoid arthritis, coeliac disease, thyroid disease and diabetes, among others. New challenges in the field receive special attention, among them genetics, molecular biology, genomics and proteomics, point-of-care testing, information technology and communication, and health economics.

“I am excited about the next chapter in the journal’s history, and delighted to continue working with Springer,” remarked Nicola Bizzaro, Editor-in-Chief for Autoimmunity Highlights. “Given Springer’s robust OA portfolio, I am confident Springer can provide the best exposure for the contents of the journal.”

Carlotta d’Imporzano, Executive Editor of Medicine Journals at Springer remarked, “We are happy to have the opportunity to grow this journal and to transition it to an open access model. The journal was always managed with scientific rigor and followed best practices in peer review, so it is not a difficult task to make Autoimmunity Highlights a part of Springer’s more than 450 open access journals.”

Springer Science+Business Media is a leading global scientific, technical and medical publisher, providing researchers in academia, scientific institutions and corporate R&D departments with quality content via innovative information products and services. Springer is also a trusted local-language publisher in Europe – especially in Germany and the Netherlands – primarily for physicians and professionals working in healthcare and road safety education. Springer published roughly 2,200 English-language journals and more than 8,400 new books in 2013, and the group is home to the world’s largest STM eBook collection, as well as the most comprehensive portfolio of open access journals. In 2013, Springer Science+Business Media generated sales of approximately EUR 943 million. The group employs more than 8,000 individuals across the globe.

More information

About Autoimmunity Highlights


Alexander K. Brown